Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,550.00
+50.00 (3.33%)
Mar 5, 2026, 8:10 AM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 78.37 million as of March 4, 2026. Its market cap has decreased by -48.22% in one year.
Market Cap
78.37M
Enterprise Value
73.29M
Revenue
13.12M
Ranking
n/a
PE Ratio
10.47
Stock Price
1,550.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 78.37M, an increase of 695.87%. That is a compound annual growth rate of 13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 75.76M | -23.88% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 135.95M |
| 4basebio | 89.77M |
| Hemogenyx Pharmaceuticals | 65.22M |
| Faron Pharmaceuticals Oy | 61.94M |
| hVIVO | 54.57M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 38.91M |
| Poolbeg Pharma | 31.73M |